Investigational Therapeutics for Patients with COVID-19


The range of medical therapeutics to treat corona virus condition 2019 (COVID-19) is growing and evolving fast, including both medicinals approved by U.S. Food and Drug Administration (FDA) and medicinals made available under FDA emergency use authorization (EUA). CDC dynamically encourages clinicians, cases and their counselors, and health system directors to regularly consult the COVID-19 Treatment Guidelines external icon published by the National Institutes of Health (NIH). The treatment and management recommendations in these guidelines are grounded on scientific proof and expert opinion and are much modernized. Current clinical management of COVID-19 consists of infection forestallment and control measures and supporting care, including supplemental oxygen and mechanical ventilatory support when indicated. FDA has approved one medicinal, remdesivir (Veklury), for the treatment of COVID-19 in certain situations.



 


    Related Conference of Investigational Therapeutics for Patients with COVID-19

    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands

    Investigational Therapeutics for Patients with COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in